Published in Eur J Pharm Sci on January 01, 2003
Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging. Bioconjug Chem (2011) 0.89
Encapsulation of docetaxel in oily core polyester nanocapsules intended for breast cancer therapy. Nanoscale Res Lett (2011) 0.86
Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study. Int J Nanomedicine (2011) 0.83
Developments in the use of nanocapsules in oncology. Braz J Med Biol Res (2013) 0.76
Lipid nanocapsule-based gels for enhancement of transdermal delivery of ketorolac tromethamine. J Drug Deliv (2011) 0.76
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer. N Engl J Med (2013) 2.38
Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials (2006) 1.94
The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. Blood (2007) 1.83
Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release (2008) 1.82
Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res (2007) 1.69
Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab (2002) 1.60
Physico-chemical stability of colloidal lipid particles. Biomaterials (2003) 1.44
Active targeting of brain tumors using nanocarriers. Biomaterials (2007) 1.42
Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis. Blood (2006) 1.35
Structure and function of a mitochondrial late embryogenesis abundant protein are revealed by desiccation. Plant Cell (2007) 1.34
Melanin is an essential component for the integrity of the cell wall of Aspergillus fumigatus conidia. BMC Microbiol (2009) 1.34
A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res (2002) 1.22
Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. Mol Ther (2003) 1.15
Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm Res (2006) 1.09
The role of pharmacologically active microcarriers releasing TGF-beta3 in cartilage formation in vivo by mesenchymal stem cells. Biomaterials (2010) 1.05
Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int J Pharm (2011) 1.03
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials (2009) 1.02
Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials (2010) 1.01
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Biomaterials (2007) 1.00
Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J Biomed Mater Res B Appl Biomater (2008) 1.00
High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma. Lab Invest (2008) 0.99
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. Nanomedicine (Lond) (2010) 0.99
Biological consequences of petite mutations in Candida glabrata. J Antimicrob Chemother (2005) 0.98
Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion. Int J Pharm (2007) 0.98
Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. Endocr Relat Cancer (2010) 0.97
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther (2006) 0.95
Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death. J Immunol (2007) 0.95
Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse. Mol Vis (2005) 0.95
The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. Biomaterials (2010) 0.92
Non-viral nanosystems for systemic siRNA delivery. Pharmacol Res (2009) 0.91
Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur J Pharm Biopharm (2008) 0.90
Brain targeting using novel lipid nanovectors. J Control Release (2007) 0.90
Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres. Eur J Pharm Biopharm (2002) 0.90
Strategies for drug delivery to the human inner ear by multifunctional nanoparticles. Nanomedicine (Lond) (2011) 0.90
The encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials (2009) 0.89
Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials (2011) 0.87
Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface. Electrophoresis (2005) 0.86
Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Int J Pharm (2010) 0.86
A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging. J Control Release (2013) 0.85
Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with (188)Re-lipid nanocapsules. Biomaterials (2011) 0.85
Surveillance of intestinal colonization and of infection by vancomycin-resistant enterococci in hospitalized cancer patients. Clin Microbiol Infect (1996) 0.85
Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties. Pharm Res (2006) 0.85
Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats. Neurosci Lett (2004) 0.83
Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Nanomedicine (Lond) (2009) 0.83
Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study. Int J Nanomedicine (2011) 0.83
Response of ovarian carcinomas to gefitinib-carboplatin-paclitaxel combination is not associated with EGFR kinase domain somatic mutations. Int J Cancer (2006) 0.83
ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform. Cell Cycle (2013) 0.83
Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization. Pharm Res (2004) 0.82
A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres. Pharm Res (2002) 0.81
Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules. Langmuir (2009) 0.81
In vitro study of GDNF release from biodegradable PLGA microspheres. J Control Release (2004) 0.81
Disruption of Candida albicans IFF4 gene involves modifications of the cell electrical surface properties. Colloids Surf B Biointerfaces (2007) 0.81
Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification. Drug Dev Ind Pharm (2006) 0.81
Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model. PLoS One (2011) 0.81
Salting-out effect induced by temperature cycling on a water/nonionic surfactant/oil system. J Phys Chem B (2007) 0.81
The influence of headgroup structure and fatty acyl chain saturation of phospholipids on monolayer behavior: a comparative rheological study. Chem Phys Lipids (2007) 0.81
New PLGA-P188-PLGA matrix enhances TGF-β3 release from pharmacologically active microcarriers and promotes chondrogenesis of mesenchymal stem cells. J Control Release (2013) 0.80
Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms. Int J Pharm (2010) 0.80
Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery. Int J Nanomedicine (2013) 0.79
Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimization. Int J Nanomedicine (2012) 0.79
FRET imaging approaches for in vitro and in vivo characterization of synthetic lipid nanoparticles. Mol Pharm (2014) 0.79
The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells. Biomaterials (2013) 0.79
Protein-loaded PLGA-PEG-PLGA microspheres: a tool for cell therapy. Eur J Pharm Sci (2011) 0.79
Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride. Eur J Pharm Biopharm (2011) 0.78
Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent. MAGMA (2008) 0.78
Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas. Head Neck (2013) 0.78
HPV-related oropharyngeal squamous cell carcinomas: a comparison between three diagnostic approaches. Am J Otolaryngol (2013) 0.78
Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma. Anticancer Res (2003) 0.78
Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules. Pharm Res (2014) 0.78
Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride. Int J Pharm (2012) 0.78
Effect of particle size on the biodistribution of lipid nanocapsules: comparison between nuclear and fluorescence imaging and counting. Int J Pharm (2013) 0.78
Evaluation of surface deformability of lipid nanocapsules by drop tensiometer technique, and its experimental assessment by dialysis and tangential flow filtration. Int J Pharm (2012) 0.77
Methods for the functionalisation of nanoparticles: new insights and perspectives. Chemistry (2010) 0.77
Preparation of PLGA microparticles by an emulsion-extraction process using glycofurol as polymer solvent. Pharm Res (2004) 0.77
Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers. Pharm Res (2009) 0.77
Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease. Neurosci Lett (2004) 0.77
A quantitative method for the determination of amphiphilic drug release kinetics from nanoparticles using a Langmuir balance. Anal Chem (2002) 0.76
OPA quantification of amino groups at the surface of lipidic nanocapsules (LNCs) for ligand coupling improvement. Int J Pharm (2011) 0.76
Effect of GDNF-releasing biodegradable microspheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts. Eur J Pharm Biopharm (2006) 0.75
Surface modification of lipid nanocapsules with polysaccharides: from physicochemical characteristics to in vivo aspects. Acta Biomater (2013) 0.75
Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease. Synapse (2002) 0.75
Interactions between poly(ethylene glycol) and protein in dichloromethane/water emulsions: a study of interfacial properties. Eur J Pharm Biopharm (2008) 0.75
Reverse micelle-loaded lipid nano-emulsions: new technology for nano-encapsulation of hydrophilic materials. Int J Pharm (2010) 0.75